Overall cohort (N = 259) | |
---|---|
Publication year, N (%) | |
2017 2018 2019 Missing/other | 8 (3.1) 1443 (55.62) 107 (41.3) 1 (0,3) |
Country of origin, N (%) | |
United States United Kingdom China Australia Canada The Netherlands Germany Other | 43 (16.6) 42 (16.2) 29 (11.2) 23 (8.9) 21 (8.1) 9 (3.5) 6 (2.3) 86 (33.2) |
Review type, N (%) | |
Systematic Scoping Integrative Health technology assessment Missing/other | 247 (95.4) 7 (2.7) 3 (1.2) 2 (0.8) 2 (0.8) |
Population, N (%) | |
Adult Pediatric Both/Unclear Animal | 131 (50.6) 29 (11.2) 96 (37.0) 3 (1.2) |
Focus of systematic review, N (%)a | |
Therapeutic Epidemiology Diagnosis Othera | 120 (46.3) 82 (31.7) 201 (7.70.8) 37 (14.32) |
Cochrane review, N (%) | |
Yes | 31 (12.0) |
No | 228 (88.0) |
Update, N (%) | |
Yes | 28 (10.8) |
No | 231 (89.2) |
Registered protocol, N (%) | |
Yes | 94 (36.3) |
No | 165 (63.7) |
Alternate screening methodologies used, N (%) | |
Crowdsourcing | 2 (0.7) |
Computer assisted screening | 1 (0.3) |